Bergenbio Asa Stock Today
| BRRGF Stock | USD 0.97 0.00 0.00% |
PerformanceWeakest
| Odds Of DistressHigh
|
BerGenBio ASA is trading at 0.97 as of the 30th of December 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.97. BerGenBio ASA has more than 66 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 30th of November 2025 and ending today, the 30th of December 2025. Click here to learn more.
BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in the developing drugs to treat immune evasive, drug resistant, and metastatic cancers. The company was incorporated in 2007 and is headquartered in Bergen, Norway. Bergenbio is traded on OTC Exchange in the United States.. The company has 88.66 M outstanding shares. More on BerGenBio ASA
Moving together with BerGenBio Pink Sheet
| 0.62 | ADVWW | Advantage Solutions | PairCorr |
| 0.91 | PCTTW | PureCycle Technologies | PairCorr |
| 0.84 | MAPSW | WM Technology | PairCorr |
| 0.93 | GCMGW | GCM Grosvenor | PairCorr |
Moving against BerGenBio Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
BerGenBio Pink Sheet Highlights
| Business Concentration | Materials, Metals & Mining, Biotechnology, Healthcare (View all Sectors) |
BerGenBio ASA [BRRGF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Small-Cap' category with a current market capitalization of 207.74 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BerGenBio ASA's market, we take the total number of its shares issued and multiply it by BerGenBio ASA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BerGenBio ASA classifies itself under Metals & Mining sector and is part of Materials industry. The entity has 88.66 M outstanding shares.
BerGenBio ASA has accumulated about 509.41 M in cash with (303.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check BerGenBio ASA Probability Of Bankruptcy
Ownership AllocationBerGenBio ASA holds a total of 88.66 Million outstanding shares. BerGenBio ASA retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check BerGenBio Ownership Details
BerGenBio ASA Risk Profiles
| Mean Deviation | 1.83 | |||
| Standard Deviation | 7.53 | |||
| Variance | 56.75 | |||
| Risk Adjusted Performance | (0.08) |
BerGenBio Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in BerGenBio ASA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Alpha Finder Now
Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk |
| All Next | Launch Module |
BerGenBio ASA Corporate Management
| Rune Skeie | Chief Officer | Profile | |
| Debbie Molyneux | Chief Officer | Profile | |
| Nigel MSc | Chief Officer | Profile | |
| Alison Messom | Director Operations | Profile | |
| James Barnes | Chief Officer | Profile | |
| Cristina MD | Chief Officer | Profile | |
| Martin Olin | Chief Officer | Profile |
Other Information on Investing in BerGenBio Pink Sheet
BerGenBio ASA financial ratios help investors to determine whether BerGenBio Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BerGenBio with respect to the benefits of owning BerGenBio ASA security.